Gossamer Bio, Inc.
GOSS
$1.14
-$0.115-9.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -6.04% | -15.24% | -17.68% | -17.16% | -19.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.51% | -11.06% | -19.23% | -20.92% | -20.50% |
| Operating Income | 65.51% | 66.77% | 66.08% | 20.92% | 20.50% |
| Income Before Tax | 69.06% | 63.54% | 63.05% | 21.82% | 21.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 68.56% | 61.77% | 60.90% | 21.82% | 21.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 68.56% | 61.77% | 60.90% | 21.82% | 21.61% |
| EBIT | 65.51% | 66.77% | 66.08% | 20.92% | 20.50% |
| EBITDA | 65.67% | 67.00% | 66.36% | 20.89% | 20.57% |
| EPS Basic | 71.42% | 81.97% | 82.36% | 57.88% | 49.48% |
| Normalized Basic EPS | 62.01% | 82.47% | 82.99% | 57.95% | 49.25% |
| EPS Diluted | 71.19% | 81.75% | 82.19% | 57.54% | 49.24% |
| Normalized Diluted EPS | 61.13% | 81.79% | 82.44% | 57.95% | 49.25% |
| Average Basic Shares Outstanding | 48.68% | 89.27% | 131.59% | 107.14% | 80.05% |
| Average Diluted Shares Outstanding | 50.71% | 91.85% | 134.86% | 107.14% | 80.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |